- Psychiatrically stable subjects with schizophrenia.
- Evidence of stable schizophrenia symptomatology greater than or equal to 3 months.
- Subjects must be on a stable medication treatment regimen greater than or equal to 2
months, including concomitant psychotropic medications.
- History of seizures or of a condition with risk of seizures.
- Subjects who have had electroconvulsive therapy within the 6 months prior to
- Pregnant or nursing females, and females of child bearing potential.